3 news items
23andMe Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results
ME
23 May 24
On March 28, 2024 the Board of Directors of 23andMe formed a Special Committee comprised of independent directors to review strategic
Petros Pharmaceuticals Launches U.S. Distribution of Prescription ED Medication STENDRA Through Recently Announced Collaboration With Lemonaid Health, a Subsidiary of 23andMe
ME
PTPI
14 May 24
. through its affiliated medical groups (subject to local laws). Prescriptions require completion of an independent medical consultation
Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros Pharmaceuticals
ME
PTPI
14 May 24
services in all 50 states and D.C. through its affiliated medical groups (subject to local laws). Prescriptions require completion of an independent
- Prev
- 1
- Next